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ABSTRACT 
This study concerned with the evaluation of antibacterial activity of crude extracts of 
three parts (leaf, fruit cover, seed cover and seed) of Swietenia mahagoni obtained by 
three solvents (acetone, ethanol and hexane). The seedoil obtained by solvent 
continuous extraction method (Soxhiet) from seed by using hexane as solvent. The 
antibacterial activity of these extracts was assessed against two multiple-drug-resistance 
bacteria strains namely, Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) 
by the well diffusion method. For the antibacterial bioassay, four concentrations (0.1, 
0.2, 0.4 and 0.8%) of each solvent and part extract solutions were prepared; DMSO was 
used to solubilize the extract in water. A control using 1% dimethyl suldoxide (DMSO) 
used for comparison. The antibacterial activity among extracts was extremely broad 
against both test organisms. With higher concentration (0.8%) the acetone extracts from 
fruit cover and leaf displayed overall more potent activity than other parts against S. 
aureus; whereas ethanol extracts from fruit and seed cover showed more efficiency 
against E. coli. However, no inhibition activity of leaf acetone and ethanol against E. 
coli with concentration of 0.8%. Bioactive groups such as alkaloid and sesquiterpene 
lactones were screened by Thin Layer Chromatography (TLC); and the results obtained 
were positive. The experimental results obtained from this study suggest that Swietenia 
mahagoni extracts are promising as natural antibacterial and this may warrant further 
research to determine the bioactive compound(s).
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ABSTRAK 
Kajian mi berkenaan dengan penilaian aktiviti antibakteria dua belas ekstrak mentah 
tiga bahagian (daun, kulit buah-buahan penutup, kulit biji benih penutup dan benih) 
Swietenia mahagoni yang diperolehi daripada tiga pelarut (aseton, etanol dan 
heksana). Minyak dari benih yang diperolehi dengan menggunakan kaedah 
pengekstrakan pelarut berterusan (Soxhiet) dari benih dengan menggunakan heksana 
sebagai pelarut. Aktiviti antibakteria pati mi telah dinilai terhadap dua bakteria-dadah-
rintangan iaitu E. co/i dan S. aureus dengan kaedah resapan. Untuk menguji 
antibakteria, empat kepekatan (0.1, 0.2, 0.4 dan 0.8%) setiap ekstrak pelarut dan 
sebahagian telah disediakan; DMSO telah digunakan untuk melarut bahan di dalam 
air. Sampel Kawalan menggunakan 1% DMSO digunakan untuk perbandingan. Aktiviti 
antibakteria di kalangan bahan adalah sangat luas terhadap kedua-dua organisma 
ujian. Dengan kepekatan yang lebih tinggi (0.8%) ekstrak aseton daripada perlindungan 
buah-buahan dan daun yang dipaparkan aktiviti keseluruhan lebih tinggi danipada 
bahagian-bahagian lain terhadap S. aureus, manakala ekstrak etanol dari buah-buahan 
clan perlindungan kulit benih menunjukkan kecekapan yang lebih terhadap E. 
coli. Walau bagaimanapun, tiada aktiviti perencatan daun aseton dan etanol terhadap E. 
coli dengan kepekatan 0.8%. Kumpulan bioaktif seperti alkaloid dan bahantara lakton 
telah ditayangkan oleh TLC; dan keputusan yang diperoleh adalah positif. Keputusan 
eksperimen yang diperolehi danipada kajian mi mencadangkan bahawa ekstrak 
Swietenia mahagoni dapat dijadikan sebagai anti-bakteria semulajadi dan mi boleh 
menjamin penyelidikan lanjutan bagi menentukan kompaun bioaktif.
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CHAPTER 1 
INTRODUCTION 
1.1 INTRODUCTION OF THE STUDY 
In the 20 century, there are sharply improves of the science and advance in 
technology in the medical field to improve the health quality of human. However, there 
are still have a lot of human affected by some of dangerous bacterial, fungus, and virus. 
For example, Human Immunodeficiency Virus (HJJ'), Rubella Virus, Stomatitis, Bacillus 
Anthrax, and Helicobacterpylori. 
Recently, hand, foot and mouth disease rash called Stomatitis have cause a lot 
baby affected and die (Chen et al., 2007). Severe acute respiratory syndrome (SARS) 
recently emerged as a human disease associated with pneumonia. This disease was first 
recognized in Guangdong Province, China, in November 2002. Subsequent to its 
introduction to Hong Kong in mid-February 2003 (Guan et al., 2003). Moreover, 
malaria is one of the main public health problems which is an incredibly common and 
dangerous infections disease have killing approximately more than one million people 
each year especially young children in Sub-Saharan Africa and placing a strong burden 
on developing African countries (Djenontin et al., 2009). 
There are a lot of vaccines, medicine, or antibacterial agents produced in the 
market to get rid of the diseases. However, many vaccines and antibacterial agents in 
the market nowadays are less efficiently. It is due to the global increase in resistance to 
antibacterial drug, including the emergence of bacterial strain that are resistant to all 
available antibacterial agents. The bacterial resist to drug though various alteration or 
mutations in their Deoxyribonucleic acid (DNA). Thus, the need for the development of
L 
newer drugs to treat infections caused by these multiple-drug resistant (MDR) bacterial 
species has never been more paramount (Gislene et al., 2000). 
The evolution drug scientists are tried to synthesis the antibacterial agents to 
against the bacterial. However, there are a lot of problems. For example, synthesis a 
new drug is too expensive, there produce many waste products in process, the drug is 
not stable and may be create toxic as by-products. Therefore, there is more favorable 
used national product to form drug. By this way, there are more safety, friendly 
environment, and cheaper in price. 
In the global, there are many extractant from plant which are treated bacterial. 
Extracts from the following plants where utilized: Achillea millfolium (yarrow), 
Caryophyllus aromaticus (clove), Melissa offfIcinalis (lemon-balm), Ocimun basilucum 
(basil), Psidium guajava (guava), Punica granatum (pomegranate), Rosmarinus 
officinalis (rosemary), Salvia officinalis (sage), Syzygyum joabolanum (jambolan) and 
Thymus vulgaris (thyme) and Swietenia mahogani (mahogany) (Nascimento et al., 
1990).
Among these plants, Swietenia mahogany (mahogany) is the most potentially in 
plant extraction as antibacterial agent. Swietenia mahogany also called west India 
mahogany (John and Francis, 1991). Its fruit is also known as "sky fruit" (Tan et al., 
2009). It comes from Meliecease family. It is large, semi-ever green tree form a loose 
rounded canopy and casts light. It is one south Florida's popular landscape and street 
trees. Mahogany can reach 75 feet in height with a 50-foot-spread. 
The extracting Swietenia mahogany especially the plant seed have medical 
efficacy. It is proven traditionally and scientific used to cure malaria, anemia, diarrhea, 
fever, dysentery, hypertension, cancer, coughs, chest pains and intestinal parasitism 
(Sathish et al., 2010). The current study of Swietenia mahogany extractions are as 
antibacterial agents. There were evaluated against multiple-drug resistant (MDR) 
Pathogenic bacteria strain such as E.coli, Staphylococcus aureus, and Salmonella 
lyphimurium. The finding will contribute to the further research for the new 
antibacterial agent.
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1.2 OBJECTIVES OF THE STUDY 
There are three objectives of this study which are: 
1. To crude extract from different parts of Swietenia mahogany by using 
different solvents (ethanol and acetone). 
2. To test antibacterial activity of Swietenia mahogany extracts against two 
types of bacteria which are Escherichia coli and Staphylococcus aureus. 
3. To determine lethal dose (LD50). 
1.3 SCOPE OF THE STUDY 
There are some important tasks to be carried out in order to achieve the objective of this 
study. Three important scopes have been identified for this study in achieving the 
objectives:
1. Study the general information of the swietenia mahogany plant and crude 
extraction of the plant in antibacterial activities. 
2. Comparing antibacterial activity and crude extract from different parts of 
Swietenia mahogany by different solvents against E. coli and S. aureus. 
3. Study the most effective crude extraction of Swietenia mahogany in 
antibacterial activity.
CHAPTER 2 
LITERATURE REVIEW 
2.1 SWIETENIA MAHOGANI PLANT 
2.1.1 Species of Swietenia Mahogani 
Swietenia mahogani also know as mahogany or West Indies mahogany in 
common name. It comes from Meliacea family (Carlos and Sergio, 2007). It is a 
tropical region of the America, mainly in Mexico, Bolivia and centre Americal. The 
genus consists of two other species, Swietenia macrophylla and Swietenia humilis. The 
three species are poorly defined biologically, in part because they hybridise freely. 
Swietenia aubrevilleana Stehie & Cusin is a putative hybrid between Swietenia 
macrophylla and Swietenia mahagoni. Figure 2.1 shows Swietenia mahogany plant and 
leaves part.
Figure 2.1: Swietenia mahogani plant and leave. 
Source: Carlos and Sergio (2007)
2.1.2 Habitat 
Swietenia mahagoni is a humid zone species, with natural distribution in the 
Caribbean region (S.Florida, Bahamas, Antilles, Haiti and Jamaica). The species is over 
exploited in much of its natural area of distribution. It has been extensively planted 
mainly in Southern Asia (India, Sri Lanka, Bangladesh) and in the Pacific (Malaysia, 
Philippines, Indonesia and Fiji), and has been introduced into cultivation in West Africa 
(Schmidt and Dorthe, 2000). The most important ecological characteristic that 
distinguishes Swietenia mahogany from Swietenia macrophylla is the ability to grow 
under dry conditions (Edward and Dennis, 1994). It occurs naturally in climates with 
annual rainfall of only 5 80-800 mm. The yields from plantations are generally lower 
than for Swietenia macrophylla but on dry sites it is superior and the wood quality is 
better. 
2.1.3 Occurrence 
This plant is Evergreen to semi-evergreen tree, up to 20-40 m height and more 
than 2 m in diameter. Mahogany species are medium to long lived, mid-succession 
species (John and Francis, 1991). The trunk of the plant is Bark grey and smooth when 
young, turning dark brown, ridged and flaky when old (Schmidt and Dorthe, 2000). 
Leaves clustered, glabrous, 12-15 cm long paripinnately compound with 2-4 pairs of 
leaflets. Leaflets ovate-lanceolate, 5-6 cm long, 2-3 cm wide, dark green, glabrous 
(Edward and Dennis, 1994). 
2.1.4 Flowering and fruiting 
The small greenish white flowers are borne in panicles attached at leaf axials 
near the ends of branches (John and Francis, 1991). Flowers are unisexual and the trees 
monoecjous (Schmidt and Dorthe, 2000). The flowers are pollinated by insects and 
usually produce only 1 fruit (a capsule) per inflorescence. Flowering generally takes 
place during the spring, with fruits ripening 9 months later (Edward and Dennis, 1994). 
However, Flowering varies according to climate example geographical site; it usually 
takes place shortly before the rainy season. Swietenia mahagoni flowers in the
Caribbean Islands between April and July and the fruits are mature 8-10 months later, 
between January and March (Schmidt and Dorthe, 2000). However, season of fruiting 
varies between portions of the range and individual trees. Occasional trees can be found 
with fruits at any season of the year in Puerto Rico (Marrero, 1949). 
Fruiting begins when trees are between 10 and 25 years old for open-grown and 
dominant or codominant trees. A few to more than a hundred capsules may be produced, 
depending on the size and vigor of the tree. Mahogany species produce good seedcrops 
nearly every year. The fruit sizes, seeds per fruit, and seeds per weight for members the 
genus are shown in Table 2.1. 
Median fruit Seeds/weight 
dimensions 
Species (cm) Seeds/fruit /kg fIb 
S.humilis 17--11 50+ 1500 680 
S.macrophylla 15--8 50-70 1400-2400 640-1100 
S.mahogani 7 ­4 35 -60 5400-7800 2500- 3500 
S. macrophylla 
mahognoni 12-- 7 45 - 65 1900-3000 860-1400 
Table 2.1: Lists of the fruit sizes, seeds per fruit, and seeds per weight for members the 
genus.
Source: (Schmidt and Dorthe, 2000) 
2.1.5 Harvest, collecting, storage 
As the fruits mature, they turn from gray-green to reddish brown. At maturity, 
the capsule walls split into 5 carpels from the bottom upwards and then fall off. The 
fruits are preferably collected from the trees just before opening or from the ground 
immediately after seeds fall. 
Small quantities of seeds can be picked up from the ground near seed-bearing 
trees. Seeds can be collected in quantity by clipping the capsules from short-statured 
trees with pruning poles after the first few capsules on a tree have opened. Mature dry 
fruits or dry seeds collected from the forest floor can be stored for some days in sacks 
without significant deterioration. However, in order to reduce bulk it is often preferable 
to initiate processing in the field. The fruits will split open when dried for 1-4 days, 
depending on maturity, after which the seeds are easily released by gentle shaking or 
raking of the fruits. Fruit parts (valves and columella) are removed by hand. Further 
reduction of bulk by manual dewing may be desired. 
Storage at ambient room temperature is about 1-2 months. Storage at 15°C 
prolongs viability to 3-6 months. Cold storage (2-5°C) with 4-5% moisture content 
extends viability up to 1 or more years (Schmidt and Dorthe, 2000). 
2.2 ANTIBACTERIAL ACTIVITY OF PLANT EXTRACTS ON 
ANTIBIOTIC RESISTANT BACTERIA 
The problem of microbial resistance is growing and the outlook for the use of 
antimicrobial drugs in the future is still uncertain. Therefore, actions must be taken to 
reduce this problem, for example, to control the use of antibiotic, develop research to 
better understand the genetic mechanisms of resistance, and to continue studies to 
develop new drugs, either synthetic or natural. The ultimate goal is to offer appropriate 
and efficient antimicrobial drugs to the patient. For a long period of time, plants have 
been a valuable source of natural products for maintaining human health, especially in 
the last decade, with more intensive studies for natural therapies. The use of plant 
compounds for pharmaceutical purposes has gradually increased in Brazil. According to 
World Health Organization medicinal plants would be the best source to obtain a variety 
of drugs. About 80% of individuals from developed countries use traditional medicine, 
which has compounds derived from medicinal plants (Santos et al., 1995). Therefore, 
such plants should be investigated to better understand their properties, safety and 
efficiency (Ellof, 1998). The use of plant extracts and phytochemicals, both with known 
antimicrobial properties, can be of great significance in therapeutic treatments. In the 
last few years, a number of studies have been conducted in different countries to prove 
such efficiency (Kubo et a!, 1993). Many plants have been used because of their 
antimicrobial traits, which are due to compounds synthesized in the secondary 
metabolism of the plant. These products are known by their active substances, for 
example, the phenolic compounds which are part of the essential oils (Jansen et al.,
1986), as well as in tannin (Saxena et al., 1994). The antimicrobial properties of plants 
have been investigated by a number of researchers world wide, especially in Latin 
America. In Argentina, a research tested 122 known plant species used for therapeutic 
treatments (Anesini and Perez, 1993). It was documented that among the compounds 
extracted from these plants, twelve inhibited the growth of Stapl'zylococus aureus, ten 
inhibited Escherichia coli, and four inhibited Aspergillus niger and also reported that the 
most potential compound was one extracted from Tabebuia impetiginosa. 
The antimicrobial properties of compounds obtained from Parthenum 
argentatum against Candida albicans, Torulopsis, Hansemula, Kiebsiella pneumoniae 
and Pseudomonas aeruginosa was detected (Martinez et al., 1994). Work done was 
observed that the substances extracted from nine known plants in Uruguai did not show 
any activity against C. albicans and Saccharomyces cerevisiae, but inhibited the growth 
of Bacillus subtilis, E. coli and P. aeruginosa (Alonso-Paz et al., 1995). Many studies 
have been conducted in Brazil. The inhibitory activity of Vatairea macrocarpa on 
Kiebsiella spp. and S. aureus was observed (Matos et al., 1988) and the inhibitory 
activity of extracts from Eucaliptus spp. against soil fungi (Bruna et al., 1989). A more 
detailed study on antimicrobial compounds was done evaluating extracts from 120 plant 
species from 28 different families. It was documented that 81 extracts obtained from 58 
plants were active against S. aureus, and five extracts from four other plants inhibited 
the growth of P. aeruginosa. Another study (Lemos et al., 1992) detected the 
antibacterial and antifungal (C. albicans) activity of essential oils obtained from Croton 
triangularis leaves. Extracts from Lippia gracilis and Xylopia sericea showed antifungal 
activity. The investigation of antimicrobial activity as well as cell toxicity of extracts 
from 30 plant species against five bacteria species and two fungi species was studied 
(Gislene et al., 2000). It was concluded that ethanol extracts from 70 % of the plants 
were toxic to cell and only one of the species of Combretum duarteanum showed 
antimicrobial activity. The toxicity of extracts from Arthemus sativa, which is known to 
have antimicrobial activity, was also studied (Carvalho et al., 1988). The antimicrobial 
activity from Mikanja friangularis, known as "thin leaf guaco", was tested against five 
genera of bacteria and three genera of yeast, and showed it had activity against Bacillus 
cereus, E. coli P. aeruginosa, S. aureus and S. epidermidis (Cruz et al., 1996). Effects 
of phytochemical were conducted (Kubo et al., 1993) and it was observed the
antimicrobial activity of anacardic acid on S. aureus, Brevibacterium ammoniagenes, 
Streptococcus mutanS and Propionibacterium acnes. Later, it was tested the bactericidal 
activity of anacardic acid and totarol on methicillin resistant strains of S. aureus 
(MRSA) and the synergistic effect of these compounds associated with methicillin 
(Muroi and Kubo, 1996). 
The antimicrobial activity of plant extracts and phytochemicals was evaluated 
with antibiotic susceptible and resistant microorganisms. In addition, the possible 
synergistic effects when associated with antibiotics were studied. Extracts from the 
following plants were utilized: Achillea millfolium (yarrow), Caiyophyllus aromaticus 
(clove), Melissa offficinalis (lemon-balm), Ocimun basilucum (basil), Psidium guajava 
(guava), Punica granatum (pomegranate), Rosmarinus officinalis (rosemary),. Salvia 
officinalis (sage), Syzygyum joabolanum (jambolan) and Thymus vulgaris (thyme). The 
phytochemicals benzoic acid, cinnamic acid, eugenol and famesol were also utilized. 
Even though pharmacological industries have produced a number of new 
antibiotics in the last three decades, resistance to these drugs by microorganisms has 
increased. In general, bacteria have the genetic ability to transmit and acquire resistance 
to drugs, which are utilized as therapeutic agents (Cohen, 1992). Such a fact is cause for 
concern, because of the number of patients in hospitals who have suppressed immunity, 
and due to new bacterial strains, which are multi-resistant. Consequently, new infections 
can occur in hospitals resulting in high mortality. From 1980 to 1990, there was 
documented a high incidence of resistant microorganisms in clinical microbiology in 
Brazil (Montelli et al., 1991). This fact has also been verified in other clinics around all 
over world. 
Hence, more studies pertaining to the use of plants as therapeutic agents should 
be emphasized, especially those related to the control of antibiotic resistant microbes. 
The objective of this research was to evaluate the potential of Swietenia mahogani 
extracts on three bacterial strains as well as multi-drug resistant bacteria, which are 
Escherjchia coli, Staphylococcus aureus and Candida albcans.
2.3 ANTIBACTERIAL AND ANTIMICROBIAL OF SWIETENIA 
MAHOGANY  EXTRACTS 
Medicinal plants are natural resources, yielding valuable herbal products which 
are often used in the treatment of various ailments (Dulger and Gonuz, 2004). In recent 
years, attempts have been taken to investigate the indigenous drugs against infectious 
diseases in order to help developing safer antimicrobial drugs (Rahman et al., 2001). In 
the continuation of this strategy there are new discovery have studied the different parts 
of the plant Swietenia mahagony for their antibacterial activities. 
Swietenia mahagony, commonly known as the West Indian Mahogany, is a 
species of Swietenia which belongs to the family Meliaceae. The plant is native to 
Southern Florida and the islands of Cuba, Jamaica and Hispaniola. The plant under 
investigation has many traditional uses. The seeds have been used for leishmaniasis and 
abortion medicine by an Amazonian Bolivian ethnic group (Bourdy et al., 2000) and for 
the treatment of hypertension, diabetes and malaria as a folk medicine in Indonesia 
(Kadota et al., 1990). The bark has been used as an astringent for wounds and 
occasionally for tanning because of the rich red color (Falah et al., 2008). 
Though the study of crude extracts from different parts (leaf, bark and seed) of 
Swietenia mahagony (Family: Meliaceae) were screened for their antibacterial activity. 
Among the crude extracts, chloroform and ethyl acetate extracts of leaf and bark 
showed good activity against all the tested organisms. The chloroform and ethyl acetate 
extracts of seed exhibited little or positive effect against most of the tested bacteria 
(Haque et al., 2009). 
Besides that, there is the study of antibacterial activity of Swietenia macrophylla 
leaf extraction. The antibacterial activities of methanol, dichioromethane and n-hexane e 
xtracts of S. macrophylla leaves were evaluated. The antimicrobial activity of the 
extracts was tested against four species of bacteria, Staphylococcus aureus, Bacillus 
subillis, Escherichia coli and Pseudomonas aeruginosa, and a fungus, Candida 
aibicans The methanol and the dichloromethane extracts were found to be active
against the Grain positive bacteria tested. The methanol extract also showed antifungal 
properties (Tan et al., 2009). 
In addition, there is the study of seed Swietenia mahogany in antibacterial 
activity analysis of Swietenia mahagoni seed oil. The oil extracted from Swietenia 
mahagoni seed was studied with a view to finding out its suitability for ethnomedical 
uses with special focus on antibacterial activities. Some of its physical and chemical 
properties were examined and compared with those of standard oils: olive, sunflower, 
cotton seed, linseed, soybean, coconut, palm and castor. The refined oil was found to 
show good to moderate activity against disease causing bacteria viz. Shigella 
dysenterial, Salmonella lyphi Staphylococcuss aureus and fungal pathogens viz. 
Macrophomina phascolma, Alternaria alternata, Curvularia lunata (Majid et al., 2004). 
For example previous study of antibacterial activity of Swietenia mahagoni crude 
methanolic seed extraction. This study was designed to evaluate the antibacterial 
activities of Swietenia mahagoni crude methanolic (SMCM) seed extract. The 
antibacterial activity of the oily extract against bacterial was evaluated based on the 
inhibition zone using disc diffusion assay, minimal inhibition concentration (MIC) and 
minimal bactericidal concentration (MBC) values. The Swietenia mahogany crude 
methonolic (SMCM) seed extract had inhibitory effects on the growth of Candida 
albicans, Staphylococcus aureus, Pseudomonas aeroginosa, Streptococcus faecalis and 
Proteus mirabillase (Sahgal et al., 2009). 
As the result, crude extracts from different parts (leaf, bark and seed) of 
Swietenia mahagony (Family: Meliaceae) show well antibacterial activities. Different 
solvent extraction in different parts of swietenia mahogany will have different 
compounds and concentration. Therefore, the extraction of the plant can used as 
antibacterial reagent in inhibition of bacterial activities such as Candida albi cans, 
Slap hylococcuss aureus, Escherichia coli and others.
2.4 ESCHERICHL4 COLI 
2.4.1 Introduction 
Escherichia coil (commonly abbreviated E. coil) is a Gram-negative, rod-
shaped bacterium that is c011ililOnly found in the lower intestine of warm-
blooded organisms. Most E. coil strains are harmless, but some serotypes can cause 
serious food poisoning in humans, and are occasionally responsible for product recalls. 
Some kinds of E. coli can cause diarrhea, while others cause urinary tract infections, 
respiratory illness and pneumonia, and other illnesses (Dippold and Vogt, 2005). The 
harmless strains are part of the normal flora of the gut, and can benefit their hosts by 
producing vitamin K2 (Bentley and Meganathan, 1982) and by preventing the 
establishment of pathogenic bacteria within the intestine. 
The genus Escherichia and Salmonella diverged 102 million years ago, which 
coincides with the divergence of their hosts: the former being found in mammals and 
the latter in birds and reptiles. This was followed by a split of the escherichian ancestor 
into five species (E.albertii, E.coii, E.fergusonii, E.hermannii and E.vulneris. The last E. 
coil ancestor split between 20 and 30 mya (Lecointre et al., 1998). 
In 1885, Theodor Escherich, a German pediatrician, first discovered this species 
in the feces of healthy individuals and called it Bacterium coil communic due to the fact 
it is found in the colon and early classifications of Prokaryotes placed these in a handful 
of genera based on their shape and motility (Daegelen et al., 2009). Bacterium coil is the 
type species of the now invalid genus Bacterium when it was revealed that the former 
type species (Bacterium triloculare) was missing (Breed and Conn, 1936). Following a 
revision of Bacteria it was reclassified as Bacillus coli by Migula in 1895 and later 
reclassified in the newly created genus Escherichia, named after its original discoverer. 
The genus belongs in a group of bacteria informally known as coliforms", and is a 
member of the Enterobacteriaceae family (the enterics) of the Gammaproteobacteria 
(George, 2005).
Ii 
2.4.2 Biochemistry of E.coli 
E. coli is Gram-negative, facultative anaerobic and nOnspOflhlating. Cells are 
typically rod-shaped, and are about 2.0 micrometers (pm) long and 0.5 f.Lm in diameter, 
with a cell volume of 0.6 - 0.7 (pm) 3 . However, the volume of E.coli will be increase 
when shift to richer media (Kubitschek, 1990). It can live on a wide variety of 
substrates. E.coli uses mixed-acid fermentation in anaerobic conditions, 
producing lactate, succinate, ethanol, acetate and carbon dioxide. Since many pathways 
in mixed-acid fermentation produce hydrogen gas, these pathways require the levels of 
hydrogen to be low, as is the case when E. coli lives together with hydrogen-consuming 
organisms, such as methanogens or sulphate-reducing bacteria. 
Optimal growth of E. coil occurs at 37°C (98.6°F) but some laboratory strains 
can multiply at temperatures of up to 49°C (120.2°F) (Fotadar et al., 2005). Growth can 
be driven by aerobic or anaerobic respiration, using a large variety of redox pairs, 
including the oxidation of pyruvic acid, formic acid, hydrogen and amino acids, and the 
reduction of substrates such as oxygen, nitrate, dimethyl sulfoxide and trimethylamine 
N-oxide (Ingledew and Poole, 1984). 
Strains that possess flagella can swim and are motile. The flagella have 
a peritrichous arrangement (Damton et al., 2006). E.coii and related bacteria possess 
the ability to transfer DNA via bacterial conjugation, transduction or transformation, 
which allows genetic material to spread horizontally through an existing population. 
This process led to the spread of the gene encoding shiga toxin from Shigelia to E. coli 
0157:H7, carried by a bacteriophage (Brussow et al., 2004). 
2.4.3 Diversity 
Escherichia coli encompass an enormous population of bacteria that exhibit a 
very high degree of both genetic and phenotypic diversity. Genome sequencing of a 
large number of isolates of E. co/i and related bacteria shows that a taxonomic 
reclassification would be desirable. However, this has not been done, largely due to its
medical importance and Escherichia coli remains one of the most diverse bacterial 
species: only 20% of the genome is common to all strains (Ussery et al., 2010). 
In fact, from the evolutionary point of view, the members of genus 
shigella (dysenteriae,flexfleri, boydii, sonnei) should be classified as E. coli strains, a 
phenomenon termed taxa in disguise (Reeves et al., 2000). Similarly, other strains of E. 
coli (e.g. the K-12 strain commonly used in recombinant DNA work) are sufficiently 
different that they would merit reclassification. 
A strain is a sub-group within the species that has unique characteristics that 
distinguish it from other strains. These differences are often detectable only at the 
molecular level; however, they may result in changes to the physiology or lifecycle of 
the bacterium. For example, a strain may gain pathogenic capacity, the ability to use a 
unique carbon source, the ability to take upon a particular ecological niche or the ability 
to resist antimicrobial agents. Different strains of E. coli are often host-specific, making 
it possible to determine the source of faucal contamination in environmental 
samples. For example, knowing which E. coil strains are present in a water sample 
allows researchers to make assumptions about whether the contamination originated 
from a human, another mammal or a bird. 
(i)	 Serotypes 
A common subdivision system of E. coii, but not based on evolutionary 
relatedness, is by serotype, which is based on major surface antigens (0 antigen: part 
of lipopolysaccharjde1ayer H: flagellin; K antigen: capsule), e.g. 01 57:H7) (Orskov et 
al., 1977) 
Serot-ypes were discovered by the Anerican microbiologist Rebecca 
Lancefield in 1933. Serotype refers to distinct variations within a subspecies of bacteria 
or viruses. These microomanisms are classified to gether based on their cell 
surface antigens. Determining serotypes, the process of serotyping, can be based on a 
Variety of factors, including virulence, lipopolysaccharides (LPS) in Gram-
negative bacteria, presence of an exotoxin (such as pertussis toxin in Bordeteiia 
perlussis), plasmids, phages, genetic profile (such as determined by polymerase chain
15 
reaction), or other characteristics which differentiate two members of the same 
species, allowing the epidemiologic classification of organisms to the sub-species level. 
A group of serovars with common antigens is called a serogroup. 
The Salmonella genus of bacteria, for example, has been determined to have over 4400 
serotypeS, including Salmonella enterica serovar Typhimurium, S. enterica serovar 
Typhi, and S. enterica serovar Dublin (Ryan and Ray, 2004). 
(ii) Genoine plasticity 
Like all lifeforms, new strains of E. coli evolve through the natural biological 
processes of mutation, gene duplication and horizontal gene transfer, in particular 18% 
of the genome of the laboratory strain MG1655 was horizontally acquired since the 
diverged from Salmonella (Lawrence and Ochman, 1998). In microbiology, all strains 
of E. coli derive from E. coli K-12 or E. coli B strains. Some strains develop traits that 
can be harmful to a host animal. These virulent strains typically cause a bout 
of diarrhea that is unpleasant in healthy adults and is often lethal to children in the 
developing world. More virulent strains, such as 0157:H7 cause serious illness or death 
in the elderly, the very young or the immunocompromised (Servin et al., 2001). 
(iii) Neotype strain 
E. coli is the type species of the genus (Escherichia) and in turn Escherichia is 
the type species of the family Enterobacterjaceae, where it should be noted that the 
family name does not stem from the genus Enterobacter + "i" (sic.) + " aceae", but from 
"enterobacterjum" + "aceae" (Euzeby, 1997). The original strain described by Escherich 
is believed to be lost, consequently a new type strain (neotype) was chosen as a 
representative :
 the neotype strain is ATCC 11775, also known as NCTC 9001, which is 
Pathogenic to chickens and has a 01:K1:H7 serotype. However, in most studies either 
0157:H7 or K-12 MG1655 or K-12 W31 10is used as a representative E.coli.
